AIM logo
AIM ImmunoTech Inc.(AIM)
Closing price · checked 4:28 PM ESTAbout this dataData status
$0.15▲0.01 (7.54%)Earnings in 5d
After Hours:$0.14-0.00 (-2.63%)
Next report

Nov 16 2026in 4 days

EPS estimate

($0.09)

Revenue estimate

$25729

EPS beats

4 of last 12

Earnings SurpriseEPS, actual vs estimateLatest -152.9%

How far reported EPS beat (+) or missed (−) the analyst estimate that stood when each report landed.

2024: -116.9%2024: -10809.1%2024: 75.7%2024: -5900.0%2025: -11.1%2025: 37.5%2025: 54.0%2025: -61.0%2026: -44.7%2026: 36.1%2026: -152.9%-116.9%75.7%-11.1%54.0%-44.7%-152.9%
Mar 29 2024Aug 7 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 7 2026($0.17)($0.43)-152.9%$100000$26000-74.0%
May 15 2026($1.08)($0.69)+36.1%$11000$11000+0.0%
Mar 27 2026($0.94)($1.36)-44.7%$100000$21000-79.0%
Nov 17 2025($0.97)($1.57)-61.0%$26000$26000+0.0%
Aug 14 2025($8.00)($3.68)+54.0%$100000$25000-75.0%
May 14 2025($8.00)($5.00)+37.5%—$16000—
Mar 27 2025($9.00)($10.00)-11.1%$100000$45000-55.0%
Nov 14 2024($0.10)($6.00)-5900.0%$17500$35000+100.0%
Aug 16 2024($12.32)($3.00)+75.7%$17500$25000+42.9%
May 16 2024($0.11)($12.00)-10809.1%—$40000—
Mar 29 2024($11.99)($26.00)-116.9%$36500$62000+69.9%
Nov 15 2023($11.33)($16.00)-41.2%$24000$46000+91.7%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+35.14%
EPS—
FY2028
Rev+50943.00%
EPS—
FY2029
Rev-99.85%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$74,000$100,000$51M$74,454$24M
Low$62,942$85,057$43M$63,328$21M
High$85,057$114,942$59M$85,579$28M
EBITDA Avg$-748,251$-252,273$7M$5M$8M
Low$-1M$-422,066$6M$5M$8M
High$-477,845$-82,480$7M$5M$9M
EBIT Avg$-926,344$-408,386$-521,689$-376,014$629,576
Low$-1M$-578,179$-713,480$-539,510$597,736
High$-655,938$-238,593$-329,899$-212,517$661,417
Net Income Avg$-1M$-874,053$-987,356.5$-841,681$129,489
Low$-2M$-1M$-1M$-1M$104,335
High$-1M$-704,260$-795,566$-678,184$154,643
EPS Avg$-0.86$-0.54$-0.61$-0.52$0.08
Low$-1.03$-0.64$-0.73$-0.62$0.06
High$-0.69$-0.44$-0.49$-0.42$0.10
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$25,462$25,197$24,935$24,676$24,420
Low$25,462$25,197$24,935$24,676$24,420
High$25,462$25,197$24,935$24,676$24,420
EBITDA Avg$-2M$-2M$-1M$-1M$-2M
Low$-2M$-2M$-1M$-1M$-2M
High$-2M$-2M$-1M$-1M$-2M
EBIT Avg$-2M$-2M$-2M$-2M$-2M
Low$-2M$-2M$-2M$-2M$-2M
High$-2M$-2M$-2M$-2M$-2M
Net Income Avg$-2M$-3M$-2M$-2M$-2M
Low$-2M$-3M$-2M$-2M$-2M
High$-2M$-3M$-2M$-2M$-2M
EPS Avg$-0.14$-0.15$-0.13$-0.13$-0.14
Low$-0.14$-0.15$-0.13$-0.13$-0.14
High$-0.14$-0.15$-0.13$-0.13$-0.14
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1

Q4 2024
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.